CoreLab Partners

CoreLab Partners is a leading, independent core lab providing best in class centralized cardiac safety services and medical imaging assessment solutions for pharmaceutical, biotechnology, and medical device sponsors of Phase I-V studies. Our commitment to service quality and scientific excellence is focused on expediting our clients’ drug development program.
CoreLab Partners is committed to providing unparalleled service quality, dedicated global capabilities and advanced technologies to improve efficiency, reduce costs and shorten timelines associated with clinical research programs. By combining proven operational processes, experienced project teams and full-time, board certified, sub-specialty trained radiologists, cardiologists, nuclear medicine physicians and oncologists, we deliver accurate, credible trial data on-time and on-budget.
Our comprehensive suite of cost effective solutions have supported greater than 725+ studies - Phase I – IV, across a broad range of imaging modalities, cardiac safety services and therapeutic indications. Further, our market leading medical imaging services are proven across more oncology trials than any other core laboratory. CoreLab Partners’ global footprint comprises more than 325 employees and offices with operational capabilities in North America, Europe and Asia.